Molecular diagnostics & genetics conference

6 February 2019

Dubai World Trade Centre

Overview:

Theme: Acquire innovative strategies in molecular diagnostics with evolving evidences and new technologies

This Molecular Diagnostics conference at MEDLAB will bring together a balance of industry and research so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on molecular and non-molecular rapid diagnostic techniques and Next Generation Sequencing.

Key topics

  • Metagenomics: A culture-independent diagnostics for bacterial blood stream infections
  • DNA Microarray in detection of emerging variants of methicillin
  • Genome editing
  • Strategies for the prevention of genetic diseases
  • Next-Generation Sequencing in oncology
  • Whole Genome Sequencing in neonatal onset of neurodegenerative disorders

Benefits of attending:

  • Review molecular and non-molecular rapid diagnostic techniques and their applications for molecular diagnostics
  • Discuss test validation and verification in the molecular laboratory
  • Examine application of gene therapy or biologic response modifiers
  • Discuss emerging trends in NGS data analysis, clinical diagnostics and biomarker development

09:50

Opening remarks

Dr Mohammed Naveed, Consultant Geneticist, Department of Paediatrics, Fujairah Hospital, Ministry of Health and Prevention, Fujairah, UAE


Session 1

Pathogen Genomics - Moderator: Dr Mohammed Naveed, Consultant Geneticist, Department of Paediatrics, Fujairah Hospital, Ministry of Health and Prevention, Fujairah, UAE

10:00

Metagenomics: A culture-independent diagnostics for bacterial blood stream infections

Dr Richard Sandford, Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK

10:30

DNA microarray in detection of emerging variants of methicillin resistant staphylococcus aureus genotypes

Dr Edet E Udo, Professor, Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait

11:00 Coffee Break


Session 2

Challenges and pitfalls - Moderator: Dr Imran Mirza, Chief, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

11:30

Challenges and pitfalls in molecular testing of tumours

Dr Jennifer L. Hunt, Chair, Department of Pathology, University of Arkansas Medical Center, Little Rock, Arkansas, USA

12:00

Barriers to providing precision medicine in the Arab world and beyond

Dr Sara Sorrell, Staff Physician, Executive Health, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

12:30

Genetic counseling in the world of genomics

Teresa Kruisselbrink, Genetics Counselors Supervisor, Mayo Clinic Center of Individualized Medicine, Rochester, Minnesota, USA

13:00 Lunch Break


Session 3

Genomic Medicine and Genome Editing - Moderator: Dr Sara Sorrell, Staff Physician, Executive Health, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

14:00

Genome editing: From bench to clinic

Dr Sumita Danda, Head, Department of Medical Genetics, Christian Medical College & Hospital Vellore, Tamil Nadu, India

14:30

Strategies for the prevention of genetic diseases in the Arab world

Dr Ghazi Tadmouri, Dean, Faculty of Public Health, Jinan University of Lebanon, Tripoli, Lebanon

15:00

Genomic screening in healthcare

Dr Imran Mirza, Chief, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

15:30 Coffee Break


Session 4

Genomics for Cancer and Rare Disease Diagnosis - Moderator: Dr Mohammed Naveed, Consultant Geneticist, Department of Paediatrics, Fujairah Hospital, Ministry of Health and Prevention, Fujairah, UAE

16:00

Next-Generation Sequencing in clinical diagnostics: Genetic testing, variant classification, and functional analysis

Rick Kamps, Head Research Technician, PhD Student, Clinical Genomics and Cell Biology, Maastricht University, Maastricht, The Netherlands

16:30

Whole Genome Sequencing in neonatal onset of neurodegenerative disorders

Dr Nuha Al Zaabi, Department of Pediatric, College of Medicine and Health Science, United Arab Emirates University, Al Ain, UAE

17:00 End of conference

Chairs:

Dr Mohammed Naveed, Consultant Geneticist & Paediatrician; Director - Planning & Operations, H.H. Sheikh Sultan Bin Khalifa Al Nahyan Humanitarian & Scientific Foundation, Dubai, UAE

Co-chair:

Dr Imran Mirza, Chief, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE


Activity Director:

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA


Speaker faculty:

Dr Edet E Udo, Professor, Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait

Dr Jennifer L. Hunt, Chair, Department of Pathology, University of Arkansas Medical Center, Little Rock, Arkansas, USA

Dr Nuha Al Zaabi, Department of Pediatric, College of Medicine and Health Science, United Arab Emirates University, Al Ain, UAE

Dr Richard Sandford, Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK

Rick Kamps, Head Research Technician, PhD Student, Clinical Genomics and Cell Biology, Maastricht University, Maastricht, The Netherlands

Dr Sara Sorrell, Staff Physician, Executive Health, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Dr Sumita Danda, Head, Department of Medical Genetics, Christian Medical College & Hospital Vellore, Tamil Nadu, India

Teresa Kruisselbrink, Genetics Counselors Supervisor, Mayo Clinic Center of Individualized Medicine, Rochester, Minnesota, USA


Accreditation statement:

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 31.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.


Provided by: